European Companies That May Be Priced Below Intrinsic Value Estimates In July 2026
The European stock market has recently experienced volatility, with the pan-European STOXX Europe 600 Index ending a turbulent week largely unchanged as investors navigated mixed corporate earnings and geopolitical tensions. Amidst these fluctuations, identifying stocks that may be priced below their intrinsic value can offer opportunities for investors looking to capitalize on potential market inefficiencies.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
| Name | Current Price | Fair Value (Est) | Discount (Est) |
| VIGO Photonics (WSE:VGO) | PLN491.00 | PLN956.57 | 48.7% |
| New Wave Group (OM:NEWA B) | SEK90.35 | SEK179.09 | 49.5% |
| Mips (OM:MIPS) | SEK378.20 | SEK748.05 | 49.4% |
| JOST Werke (XTRA:JST) | €55.70 | €111.34 | 50% |
| ERAMET (ENXTPA:ERA) | €42.40 | €83.52 | 49.2% |
| Casta Diva Group (BIT:CDG) | €3.02 | €6.03 | 49.9% |
| Cambi (OB:CAMBI) | NOK21.50 | NOK42.71 | 49.7% |
| Atea (OB:ATEA) | NOK163.60 | NOK318.79 | 48.7% |
| Altri SGPS (ENXTLS:ALTR) | €4.66 | €9.08 | 48.7% |
| Allgeier (XTRA:AEIN) | €16.00 | €31.99 | 50% |
Underneath we present a selection of stocks filtered out by our screen.
Amplifon (BIT:AMP)
Overview: Amplifon S.p.A. specializes in distributing hearing solutions and fitting customized products across Europe, the Middle East, Africa, the Americas, and the Asia Pacific with a market cap of €2.90 billion.
Operations: The company's revenue primarily comes from the distribution and personalization of hearing solutions, amounting to €2.39 billion.
Estimated Discount To Fair Value: 41%
Amplifon appears undervalued based on cash flows, trading at €10.94 against a future cash flow value estimate of €18.53. Despite high debt and recent shareholder dilution, earnings are projected to grow significantly at 30.34% annually, outpacing the Italian market's 11%. However, profit margins have decreased from last year and dividends remain inadequately covered by earnings. Recent equity offerings raised €453 million but may impact share value in the short term.
- Upon reviewing our latest growth report, Amplifon's projected financial performance appears quite optimistic.
- Navigate through the intricacies of Amplifon with our comprehensive financial health report here.
BioGaia (OM:BIOG B)
Overview: BioGaia AB is a healthcare company that develops, manufactures, markets, and sells probiotic products for gut, oral, and immune health across various regions including Europe, the Middle East, Africa, the United States, Asia-Pacific, Australia, and New Zealand with a market cap of approximately SEK11.96 billion.
Operations: The company's revenue is primarily derived from its Pediatrics segment, generating SEK1.18 billion, followed by the Adult Health segment with SEK393.15 million.
Estimated Discount To Fair Value: 33.1%
BioGaia trades at SEK118.2, significantly below its estimated future cash flow value of SEK176.59, suggesting undervaluation based on cash flows. Earnings grew 21.1% last year and are forecast to grow 17.7% annually, outpacing the Swedish market's growth rate of 7.3%. However, its dividend yield of 3.38% isn't well covered by free cash flows. Recent earnings reports show steady sales and income growth, while product expansions in skincare may enhance future revenue streams.
- Our earnings growth report unveils the potential for significant increases in BioGaia's future results.
- Take a closer look at BioGaia's balance sheet health here in our report.
NCAB Group (OM:NCAB)
Overview: NCAB Group AB (publ) specializes in the manufacture and sale of printed circuit boards across Sweden, the Nordic region, Europe, North America, and Asia, with a market capitalization of approximately SEK14.57 billion.
Operations: NCAB Group AB (publ) generates revenue through the manufacture and sale of printed circuit boards in Sweden, the Nordic region, Europe, North America, and Asia.
Estimated Discount To Fair Value: 16.8%
NCAB Group, trading at SEK77.9, is undervalued compared to its estimated future cash flow value of SEK93.61. The company reported a substantial increase in net income for Q2 2026, reaching SEK84.3 million from SEK40.3 million the previous year, with earnings per share doubling to SEK0.45. Despite high debt levels, NCAB's earnings are projected to grow significantly at 26.6% annually over the next three years, surpassing Swedish market growth rates.
- The growth report we've compiled suggests that NCAB Group's future prospects could be on the up.
- Get an in-depth perspective on NCAB Group's balance sheet by reading our health report here.
Make It Happen
- Access the full spectrum of 209 Undervalued European Stocks Based On Cash Flows by clicking on this link.
- Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
- Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com